NITI Aayog Launches 10-Year Roadmap Targeting USD 691 Billion Bioeconomy by 2035
NITI Aayog launched the 'Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035' in July 2026 at the National Media Centre, New Delhi. It was formally released by Dr. Jitendra Singh, Union Minister of State (Independent Charge) for Science & Technology, in the presence of Prof. Gobardhan Das (Member, NITI Aayog) and Nidhi Chhibber (CEO, NITI Aayog). Developed by: the NITI Frontier Tech Hub (NITI-FTH) in consultation with the Department of Biotechnology (DBT), the Association of Biotechnology Led Enterprises (ABLE), industry and academia. Key targets: Scale India's bioeconomy to USD 691 billion by 2035 and USD 2.6 trillion by 2047; generate over 30 million high-value jobs; and place India among the world's top 3 biotechnology powers. India's bioeconomy was valued at about USD 195.3 billion in 2025. Six National BioMissions are recommended: GeneIndia, AgriBio 2.0, BioX Foundry, One Health Grid, Marine Biotechnology and BioPharmaNext — covering advanced therapeutics, climate-resilient agriculture, synthetic biology, pandemic preparedness, marine biotech and next-generation biopharmaceuticals. Key proposal: a Rs 50,000 crore BioEconomy Growth Fund for 2026-2035, carved out of the existing Rs 1 lakh crore Research, Development and Innovation (RDI) framework, to bridge the 'valley of death' between proof-of-concept research and commercial-scale manufacturing. New institutions proposed: an Empowered Committee on National BioMissions, a National BioData Council, a BioEconomy Investment and Policy Forum, and a BioIP and Innovation Evaluation Agency.
NITI Aayog established: 1 January 2015, replacing the Planning Commission (1950) | Chairperson: the Prime Minister | CEO: Nidhi Chhibber | HQ: New Delhi | Department of Biotechnology set up: 1986, under the Ministry of Science & Technology
NITI Aayog released the 'Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035', targeting a USD 691 billion bioeconomy by 2035 and USD 2.6 trillion by 2047, with 30 million+ new jobs. • The roadmap proposes a Rs 50,000 crore BioEconomy Growth Fund (2026-2035) and six National BioMissions — GeneIndia, AgriBio 2.0, BioX Foundry, One Health Grid, Marine Biotechnology and BioPharmaNext.